Login Join for free
Popular Searches
Popular news More >
SEARCHING....
no results found
  • Real Time Chart Real Time Chart
  • Stock Profile Stock Profile

  • Financials As Reported

    • accession Number 0001370368-22-000010
    • amendment Flag false
    • assets 131,795,000,000
    • auditor Firm Id 1,358
    • auditor Location Basel, Switzerland
    • auditor Name PricewaterhouseCoopers AG
    • cik 1,114,448
    • current Fiscal Year End Date --12-31
    • date Filed 2022-02-02
    • document Annual Report true
    • document Fiscal Period Focus FY
    • document Fiscal Year Focus 2,021
    • document Period End Date 2021-12-31
    • document Transition Report false
    • document Type 20-F
    • entity Address Address Line 1 Lichtstrasse 35
    • entity Address City Or Town Basel
    • entity Address Postal Zip Code 4,056
    • entity Central Index Key 1,114,448
    • entity Current Reporting Status Yes
    • entity Emerging Growth Company false
    • entity File Number 1-15024
    • entity Filer Category Large Accelerated Filer
    • entity Incorporation State Country Code V8
    • entity Interactive Data Current Yes
    • entity Name NOVARTIS AG
    • entity Registrant Name Novartis AG
    • entity Shell Company false
    • entity Voluntary Filers No
    • entity Well Known Seasoned Issuer Yes
    • gross Profit 37,010,000,000
    • icfr Auditor Attestation Flag true
    • interest Expense 811,000,000
    • irs Number 0
    • liabilities 63,973,000,000
    • noncurrent Assets 86,077,000,000
    • period End 1,640,908,800,000
    • period Start 1,609,459,200,000
    • report Link https://www.sec.gov/Archives/edgar/data/1114448/000137036822000010/nvs-20211231_htm.xml
    • research And Development Expense 9,540,000,000
    • selling General And Administrative Expense 14,886,000,000
    • trading Symbol NVS
    • update 1970-01-01
    • id REPORTED_FINANCIALS
    • key NVS
    • subkey 20-F
    • date 2022-02-02
    • updated 2022-05-14
  • Symbol Info Symbol Info
  • Symbol Over View Symbol Over View
  • Technical Analysis Technical Analysis

NVS stock fundamentals - financials as reported

Financials As Reported

  • accession Number 0001370368-22-000010
  • amendment Flag false
  • assets 131,795,000,000
  • auditor Firm Id 1,358
  • auditor Location Basel, Switzerland
  • auditor Name PricewaterhouseCoopers AG
  • cik 1,114,448
  • current Fiscal Year End Date --12-31
  • date Filed 2022-02-02
  • document Annual Report true
  • document Fiscal Period Focus FY
  • document Fiscal Year Focus 2,021
  • document Period End Date 2021-12-31
  • document Transition Report false
  • document Type 20-F
  • entity Address Address Line 1 Lichtstrasse 35
  • entity Address City Or Town Basel
  • entity Address Postal Zip Code 4,056
  • entity Central Index Key 1,114,448
  • entity Current Reporting Status Yes
  • entity Emerging Growth Company false
  • entity File Number 1-15024
  • entity Filer Category Large Accelerated Filer
  • entity Incorporation State Country Code V8
  • entity Interactive Data Current Yes
  • entity Name NOVARTIS AG
  • entity Registrant Name Novartis AG
  • entity Shell Company false
  • entity Voluntary Filers No
  • entity Well Known Seasoned Issuer Yes
  • gross Profit 37,010,000,000
  • icfr Auditor Attestation Flag true
  • interest Expense 811,000,000
  • irs Number 0
  • liabilities 63,973,000,000
  • noncurrent Assets 86,077,000,000
  • period End 1,640,908,800,000
  • period Start 1,609,459,200,000
  • report Link https://www.sec.gov/Archives/edgar/data/1114448/000137036822000010/nvs-20211231_htm.xml
  • research And Development Expense 9,540,000,000
  • selling General And Administrative Expense 14,886,000,000
  • trading Symbol NVS
  • update 1970-01-01
  • id REPORTED_FINANCIALS
  • key NVS
  • subkey 20-F
  • date 2022-02-02
  • updated 2022-05-14

Related News

QQQ ETF ($706.22) Slides 7.4% Below Its High as the Market Reprices the AI Capex Bill — $686.57 Target if $700 Breaks

QQQ ETF ($706.22) Slides 7.4% Below Its High as the Market Reprices the AI Capex Bill — $686.57 Target if $700 Breaks

TradingNEWS Archive 22.10.26
Stocks Markets AMZN MSFT NVDA META
META ($660.00) Swings 12.1% From After-Hours High as Capex Floor Rises to $135B — $600 Target if $648.74 Breaks

META ($660.00) Swings 12.1% From After-Hours High as Capex Floor Rises to $135B — $600 Target if $648.74 Breaks

Itai Smidt 22.10.26
Stocks META PINS SNAP RDDT
S&P 500 7,757, Nasdaq 26,703, Dow 52,856 Face AI Selloff as META, TSLA, LRCX Slide

S&P 500 7,757, Nasdaq 26,703, Dow 52,856 Face AI Selloff as META, TSLA, LRCX Slide

Itai Smidt 22.10.26
Stocks Markets IBM LRCX TSLA META
SMCX ETF ($9.83) Delivers a Clean 2x Day on Super Micro’s Beat — Meta Capex and November 3 Cash Flow Decide $12.88 or $8.13

SMCX ETF ($9.83) Delivers a Clean 2x Day on Super Micro’s Beat — Meta Capex and November 3 Cash Flow Decide $12.88 or $8.13

Itai Smidt 21.10.26
Stocks Markets SMCI MU NVDA AMD
NFLX ($65.69) Trades at 19x Earnings Despite a 34.6% Margin — Path Back to $72.56 Needs Engagement Proof

NFLX ($65.69) Trades at 19x Earnings Despite a 34.6% Margin — Path Back to $72.56 Needs Engagement Proof

Itai Smidt 21.10.26
Stocks NFLX WBD DIS AMZN
TSLA ($386.95) Runs 9% in 4 Sessions on Merger Talk — Q3 Margins Decide $415 or $360

TSLA ($386.95) Runs 9% in 4 Sessions on Merger Talk — Q3 Margins Decide $415 or $360

Itai Smidt 21.10.26
Stocks TSLA GM F TM
Trade Now
© Trading News. All Rights Reserved Since 2022